Literature DB >> 32386844

Sarcopenia in Korean Community-Dwelling Adults Aged 70 Years and Older: Application of Screening and Diagnostic Tools From the Asian Working Group for Sarcopenia 2019 Update.

Miji Kim1, Chang Won Won2.   

Abstract

OBJECTIVE: To describe the prevalence of sarcopenia in a large group of community-dwelling older adults using the Asian Working Group for Sarcopenia (AWGS) 2019 definition and algorithm.
DESIGN: Cross-sectional data analysis of a cohort study.
SETTING: The Nationwide Korean Frailty and Aging Cohort Study (KFACS). PARTICIPANTS: A total of 2123 ambulatory community-dwelling older adults, aged 70 to 84 years (mean, 75.9 ± 3.9 years; 49.5% women) were enrolled in the KFACS.
METHODS: Appendicular skeletal muscle mass was measured by dual-energy x-ray absorptiometry. Physical function was assessed by handgrip strength, usual gait speed, the 5-times-sit-to-stand test, the timed up-and-go test, and the Short Physical Performance Battery. In a case-finding assessment, screening for sarcopenia was performed using the calf circumference (CC), SARC-F questionnaire, and SARC-F combined with CC (SARC-CalF).
RESULTS: According to the AWGS 2019 algorithm, 43.5%, 7.5%, and 26.0% of the subjects in the whole study sample were classified as those at risk for sarcopenia according to CC, SARC-F, and SARC-CalF, respectively. The prevalence rates of possible sarcopenia using 3 screening tools for case-finding and muscle strength or physical performance tests according to the AWGS 2019 diagnostic algorithm were 20.1% in men and 29.2% in women. The prevalence rates of sarcopenia, when defined as low muscle mass plus low handgrip strength and/or slow gait speed, were significantly higher according to the AWGS 2019 (21.3% in men and 13.8% in women) than the AWGS 2014 (10.3% in men and 8.1% in women) definitions. The prevalence of severe sarcopenia was 6.4% in men and 3.2% in women. CONCLUSIONS/IMPLICATIONS: The results of our study suggest that the use of CC and SARC-CalF to screen for possible sarcopenia may be more suited than using the SARC-F questionnaire alone according to the AWGS 2019 diagnostic algorithm in community-dwelling adults aged 70 to 84 years. The prevalence of sarcopenia was significantly higher according to the AWGS 2019 than AWGS 2014 criteria.
Copyright © 2020 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AWGS 2019; Sarcopenia; community-dwelling older adults; low muscle function; screening tool

Mesh:

Year:  2020        PMID: 32386844     DOI: 10.1016/j.jamda.2020.03.018

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  17 in total

1.  Limitations of SARC-F as a Screening Tool for Sarcopenia in Patients on Hemodialysis.

Authors:  Keigo Imamura; Shohei Yamamoto; Yuta Suzuki; Ryota Matsuzawa; Manae Harada; Shun Yoshikoshi; Atsushi Yoshida; Atsuhiko Matsunaga
Journal:  Nephron       Date:  2021-09-14       Impact factor: 2.847

2.  Prevalence and associated factors of possible sarcopenia and sarcopenia: findings from a Chinese community-dwelling old adults cross-sectional study.

Authors:  Jiazhi Wang; Changge Liu; Lin Zhang; Ning Liu; Lei Wang; Jingqiong Wu; Yizhao Wang; Huimin Hao; Longjun Cao; Shilei Yuan; Liping Huang
Journal:  BMC Geriatr       Date:  2022-07-18       Impact factor: 4.070

3.  Accuracy of Calf Circumference Measurement, SARC-F Questionnaire, and Ishii's Score for Screening Stroke-Related Sarcopenia.

Authors:  Ruihong Yao; Liqing Yao; Changli Yuan; Bu-Lang Gao
Journal:  Front Neurol       Date:  2022-04-29       Impact factor: 4.086

4.  Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement.

Authors:  Lorenzo M Donini; Luca Busetto; Stephan C Bischoff; Tommy Cederholm; Maria D Ballesteros-Pomar; John A Batsis; Juergen M Bauer; Yves Boirie; Alfonso J Cruz-Jentoft; Dror Dicker; Stefano Frara; Gema Frühbeck; Laurence Genton; Yftach Gepner; Andrea Giustina; Maria Cristina Gonzalez; Ho-Seong Han; Steven B Heymsfield; Takashi Higashiguchi; Alessandro Laviano; Andrea Lenzi; Ibolya Nyulasi; Edda Parrinello; Eleonora Poggiogalle; Carla M Prado; Javier Salvador; Yves Rolland; Ferruccio Santini; Mireille J Serlie; Hanping Shi; Cornel C Sieber; Mario Siervo; Roberto Vettor; Dennis T Villareal; Dorothee Volkert; Jianchun Yu; Mauro Zamboni; Rocco Barazzoni
Journal:  Obes Facts       Date:  2022-02-23       Impact factor: 4.807

5.  SARC-F as a case-finding tool for sarcopenia according to the EWGSOP2. National validation and comparison with other diagnostic standards.

Authors:  Karolina Piotrowicz; Anna Głuszewska; Joanna Czesak; Małgorzata Fedyk-Łukasik; Ewa Klimek; Dolores Sánchez-Rodríguez; Anna Skalska; Barbara Gryglewska; Tomasz Grodzicki; Jerzy Gąsowski
Journal:  Aging Clin Exp Res       Date:  2021-01-28       Impact factor: 3.636

6.  Validation of the Thai version of SARC-F, MSRA-7, and MSRA-5 questionnaires compared to AWGS 2019 and sarcopenia risks in older patients at a medical outpatient clinic.

Authors:  Phuriwat Akarapornkrailert; Weerasak Muangpaisan; Apinya Boonpeng; Dao Daengdee
Journal:  Osteoporos Sarcopenia       Date:  2020-11-26

7.  Sarcopenia prevalence and associated factors among older Chinese population: Findings from the China Health and Retirement Longitudinal Study.

Authors:  Xin Wu; Xue Li; Meihong Xu; Zhaofeng Zhang; Lixia He; Yong Li
Journal:  PLoS One       Date:  2021-03-04       Impact factor: 3.240

8.  Prevalence, Incidence, and Associated Factors of Possible Sarcopenia in Community-Dwelling Chinese Older Adults: A Population-Based Longitudinal Study.

Authors:  Zi Chen; Mandy Ho; Pui Hing Chau
Journal:  Front Med (Lausanne)       Date:  2022-01-10

Review 9.  Vitamin D and Sarcopenia: Potential of Vitamin D Supplementation in Sarcopenia Prevention and Treatment.

Authors:  Ran Uchitomi; Mamoru Oyabu; Yasutomi Kamei
Journal:  Nutrients       Date:  2020-10-19       Impact factor: 5.717

10.  Mid-Upper Arm Circumference as an Alternative Screening Instrument to Appendicular Skeletal Muscle Mass Index for Diagnosing Sarcopenia.

Authors:  Feng-Juan Hu; Hu Liu; Xiao-Lei Liu; Shu-Li Jia; Li-Sha Hou; Xin Xia; Bi-Rong Dong
Journal:  Clin Interv Aging       Date:  2021-06-15       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.